Table 1 Demographic and tumor characteristics (N = 168)
Characteristics | Sub-categories | No. (%) | |
|---|---|---|---|
Age (yrs) | Mean = 63.4 yrs | Range (28, 87) | |
Gender | Male | 103 | (61.7) |
| Â | Female | 65 | (38.3) |
Laterality | Left | 82 | (49.1) |
| Â | Right | 85 | (50.9) |
Tumor Size (Imaging) | 1–2 cm | 45 | (26.9) |
| Â | 2.1-4Â cm | 123 | (73.1) |
Internal structure | Solid | 90 | (53.3) |
| Â | Solid cystic | 9 | (5.4) |
| Â | Unknown | 69 | (41.3) |
Enhancement | Enhancing | 98 | (57.5) |
| Â | Non-enhancing | 4 | (2.4) |
| Â | Unknown | 66 | (39.6) |
Modality | US-guided | 48 | (28.6) |
| Â | CT-guided | 119 | (70.8) |
|  | US + CT | 1 | (0.6) |
Number of Cores | 1–2 | 47 | (28.1) |
|  | 3–4 | 93 | (55.1) |
|  | 5–6 | 22 | (13.2) |
| Â | 7 and more | 5 | (3.0) |
Side effect | Hemorrhage | 5 | (3.0) |
| Â | Tumor Seeding | 0 | (0.0) |
| Â | Severe pain | 3 | (1.8) |
| Â | Infection | 1 | (0.6) |
| Â | Hematuria | 3 | (1.8) |
Treatment | Surgery | 63 | (37.5) |
| Â | Ablation | 41 | (24.4) |
| Â | Surveillance | 50 | (29.8) |
| Â | Chemotherapy | 2 | (1.2) |
| Â | No follow up | 12 | (7.1) |